Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Moleculin BiotechOcuphire PharmaAvenue TherapeuticsProPhase LabsHelix BioPharma
SymbolNASDAQ:MBRXNASDAQ:OCUPNASDAQ:ATXINASDAQ:PRPHOTCMKTS:HBPCF
Price Information
Current Price$3.79$5.94$6.86$5.28$0.72
52 Week RangeBuyBuyHoldBuyN/A
MarketRank™
Overall Score1.22.00.81.10.5
Analysis Score3.53.51.03.50.0
Community Score2.75.02.22.22.3
Dividend Score0.00.00.00.00.0
Ownership Score0.00.80.00.00.0
Earnings & Valuation Score0.00.60.60.00.0
Analyst Ratings
Consensus RecommendationBuyBuyHoldBuyN/A
Consensus Price Target$15.00$21.75$6.00$25.00N/A
% Upside from Price Target295.78% upside266.16% upside-12.54% downside373.48% upsideN/A
Trade Information
Market Cap$107.80 million$64.92 million$114.89 million$80.01 million$101.62 million
Beta2.110.760.710.240.04
Average Volume2,817,425316,970216,841346,8551,844
Sales & Book Value
Annual RevenueN/AN/AN/A$9.88 millionN/A
Price / SalesN/AN/AN/A8.10N/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$0.34 per share$9.91 per share$0.41 per share$0.97 per share$0.02 per share
Price / BookN/AN/AN/A5.44N/A
Profitability
Net Income$-13,200,000.00$-8,640,000.00$-25,910,000.00$-3,150,000.00$-6,680,000.00
EPS($0.32)N/A($1.65)N/AN/A
Trailing P/E RatioN/A0.00N/A0.000.00
Forward P/E RatioN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/A-12.92%N/A
Return on Equity (ROE)-113.25%-79.33%-192.35%-15.95%-325.42%
Return on Assets (ROA)-63.20%-58.43%-151.39%-11.65%-193.46%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/AN/A0.93%N/A
Current Ratio4.44%2.88%3.89%8.35%2.22%
Quick Ratio4.44%2.88%3.89%7.35%2.22%
Ownership Information
Institutional Ownership Percentage4.82%63.71%16.39%3.92%N/A
Insider Ownership Percentage8.30%1.10%4.00%29.20%7.60%
Miscellaneous
Employees11544810
Shares Outstanding28.44 million10.93 million16.75 million15.15 million141.13 million
Next Earnings Date5/10/2021 (Estimated)5/6/2021 (Estimated)5/10/2021 (Estimated)5/11/2021 (Estimated)7/29/2021 (Estimated)
OptionableNot OptionableNot OptionableNot OptionableNot OptionableNot Optionable
SourceHeadline
Helix BioPharma Corp. Extends Period to Exercise WarrantsHelix BioPharma Corp. Extends Period to Exercise Warrants
finance.yahoo.com - April 9 at 6:50 PM
HBP.TO: LDOS006 New Sites OpenHBP.TO: LDOS006 New Sites Open
finance.yahoo.com - April 5 at 1:10 PM
Helix BioPharma Corp. (OTCMKTS:HBPCF) Short Interest UpdateHelix BioPharma Corp. (OTCMKTS:HBPCF) Short Interest Update
americanbankingnews.com - March 29 at 1:28 AM
NA Proactive news snapshot: American Battery Metals, Victory Square Technologies, Gevo, Metalla Royalty & Streaming UPDATENA Proactive news snapshot: American Battery Metals, Victory Square Technologies, Gevo, Metalla Royalty & Streaming UPDATE
proactiveinvestors.com - March 17 at 6:41 PM
NA Proactive news snapshot: Renforth Resources, Psyched Wellness, Ascendant Resources, KULR TechnologyNA Proactive news snapshot: Renforth Resources, Psyched Wellness, Ascendant Resources, KULR Technology
proactiveinvestors.com - March 17 at 1:40 PM
NA Proactive news snapshot: Vuzix Corporation, VR Resources, Todos Medical, Marvel Discovery UPDATENA Proactive news snapshot: Vuzix Corporation, VR Resources, Todos Medical, Marvel Discovery UPDATE
proactiveinvestors.com - March 17 at 1:40 PM
Helix Biopharma: Fiscal Q2 Earnings SnapshotHelix Biopharma: Fiscal Q2 Earnings Snapshot
sfgate.com - March 16 at 7:34 PM
Helix BioPharma Corp. Appoints Dr. Frank Gary Renshaw To Scientific Advisory BoardHelix BioPharma Corp. Appoints Dr. Frank Gary Renshaw To Scientific Advisory Board
finance.yahoo.com - February 16 at 8:33 AM
Helix Biopharma Corp. Responds to Market ActivityHelix Biopharma Corp. Responds to Market Activity
finance.yahoo.com - January 13 at 4:38 PM
NA Proactive news snapshot: FansUnite Entertainment, First Cobalt, Newrange Gold, Innocan Pharma, Great Panther Mining UPDATE ...NA Proactive news snapshot: FansUnite Entertainment, First Cobalt, Newrange Gold, Innocan Pharma, Great Panther Mining UPDATE ...
proactiveinvestors.com - December 16 at 9:28 PM
HBP.TO: Polish Subsidiary Definitive SaleHBP.TO: Polish Subsidiary Definitive Sale
finance.yahoo.com - November 30 at 12:04 PM
CAIAC Fund Management AG Acquires Securities of  Helix Biopharma Corp.CAIAC Fund Management AG Acquires Securities of Helix Biopharma Corp.
financialpost.com - August 28 at 3:20 PM
Helix BioPharma and Moffitt Cancer center extends immunotherapy collaborationHelix BioPharma and Moffitt Cancer center extends immunotherapy collaboration
seekingalpha.com - August 12 at 1:21 PM
Helix BioPharma Corp. and Moffitt Cancer Center Extend Immunotherapy CollaborationHelix BioPharma Corp. and Moffitt Cancer Center Extend Immunotherapy Collaboration
finance.yahoo.com - August 12 at 8:13 AM
HBP.TO: Helix BioPharma Announces 3Q:20 ResultsHBP.TO: Helix BioPharma Announces 3Q:20 Results
finance.yahoo.com - August 10 at 11:14 AM
49 Public Companies to Present at the SNN Network Virtual Conference on August 3-6, 202049 Public Companies to Present at the SNN Network Virtual Conference on August 3-6, 2020
finance.yahoo.com - August 3 at 8:11 AM
Helix BioPharma Corp. to Present at the SNN Network Virtual ConferenceHelix BioPharma Corp. to Present at the SNN Network Virtual Conference
finance.yahoo.com - July 31 at 6:35 PM
Helix Biopharma: Fiscal 3Q Earnings SnapshotHelix Biopharma: Fiscal 3Q Earnings Snapshot
journalstar.com - July 30 at 11:16 PM
Helix Biopharma Corp. Announces Fiscal Third Quarter 2020 ResultsHelix Biopharma Corp. Announces Fiscal Third Quarter 2020 Results
business.financialpost.com - July 30 at 5:58 PM
Helix BioPharma Corp. to Present at Alpha Bronze Virtual Town HallHelix BioPharma Corp. to Present at Alpha Bronze Virtual Town Hall
finance.yahoo.com - July 27 at 9:05 AM
HBP.TO: Helix BioPharma Pitches at Proactive’s One2One Virtual ForumHBP.TO: Helix BioPharma Pitches at Proactive’s One2One Virtual Forum
finance.yahoo.com - June 24 at 3:06 PM
Have Insiders Been Buying Helix BioPharma Corp. (TSE:HBP) Shares This Year?Have Insiders Been Buying Helix BioPharma Corp. (TSE:HBP) Shares This Year?
finance.yahoo.com - May 20 at 9:52 AM
Helix BioPharma announces data from L-DOS47 dose escalation study of non-small cell lung cancer patientsHelix BioPharma announces data from L-DOS47 dose escalation study of non-small cell lung cancer patients
www.proactiveinvestors.com - May 14 at 9:09 AM
HBP.TO: Pancreatic Trial EnrollingHBP.TO: Pancreatic Trial Enrolling
finance.yahoo.com - April 6 at 3:15 PM
Helix BioPharma maintaining business continuity amid coronavirus pandemicHelix BioPharma maintaining business continuity amid coronavirus pandemic
www.proactiveinvestors.com - April 2 at 3:43 PM
DateCompanyBrokerageAction
6/25/2020Moleculin BiotechOppenheimerReiterated Rating
6/9/2020Moleculin BiotechMaxim GroupInitiated Coverage
11/18/2019Moleculin BiotechRoth CapitalReiterated Rating
4/5/2021Ocuphire PharmaAlliance Global PartnersInitiated Coverage
3/29/2021Ocuphire PharmaJonestradingInitiated Coverage
3/22/2021Ocuphire PharmaCantor FitzgeraldBoost Price Target
2/10/2021Ocuphire PharmaCanaccord GenuityInitiated Coverage
12/18/2020Avenue TherapeuticsHC WainwrightReiterated Rating
1/20/2021ProPhase LabsDawson JamesInitiated Coverage
(Data available from 4/10/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.